Match!

Will genomics revolutionise pharmaceutical R&D?

Published on Aug 1, 2003in Trends in Biotechnology13.747
· DOI :10.1016/S0167-7799(03)00162-8
Denis Noble68
Estimated H-index: 68
(University of Oxford)
Abstract
The successful identification of drug targets requires an understanding of the high-level functional interactions between the key components of cells, organs and systems, and how these interactions change in disease states. This information does not reside in the genome, or in the individual proteins that genes code for, it is to be found at a higher level. Genomics will succeed in revolutionising pharmaceutical research and development only if these interactions are also understood by determining the logic of healthy and diseased states. The rapid growth in biological databases, models of cells, tissues and organs, and in computing power has made it possible to explore functionality all the way from the level of genes to whole organs and systems. Combined with genomic and proteomic data, in silico simulation technology is set to transform all stages of drug discovery and development. The major obstacle to achieving this will be obtaining the relevant experimental data at levels higher than genomics and proteomics.
  • References (23)
  • Citations (12)
📖 Papers frequently viewed together
41 Citations
14 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References23
Newest
Simulation of sodium-calcium exchange activity during the rise of intracellular sodium that occurs during ischemia suggests that the exchanger may not reverse direction except transiently during calcium oscillations. This conclusion depends on the presence of a small resting leak of calcium into the cell, consistent with radioactive calcium flux measurements. The conditions for intracellular calcium to rise to around 3 microM were explored. A combination of extracellular potassium accumulation a...
20 CitationsSource
#1Denis Noble (University of Oxford)H-Index: 68
Mathematical models of the heart have developed over a period of about 40 years. Cell types in all regions of the heart have been modelled and they are now being incorporated into anatomically detailed models of the whole organ. This combination is leading to the creation of the first ‘virtual organ,’ which is being used in drug discovery and testing, and in simulating the action of devices, such as cardiac defibrillators. Simulation is a necessary tool of analysis in attempting to understand bi...
86 CitationsSource
#1Gregory BockH-Index: 23
#2Jamie GoodeH-Index: 20
Chair's Introduction (D. Noble). Integrative biological modelling in silico (A. McCulloch and G. Huber). Advances in computing, and their impact on scientific computing (M. Giles). From physics to phenomenology: Levels of description and levels of selection (D. Krakauer). Making sense of complex phenomena in biology (P. Maini). On ontologies for biologists: the Gene Ontology-untangling the web (M. Ashburner and S. Lewis). General discussion I: Model validation. The KEGG database (M. Kanehisa). S...
23 CitationsSource
#1Peter Hunter (University of Auckland)H-Index: 63
#2Peter A. Robbins (University of Oxford)H-Index: 46
Last. Denis Noble (University of Oxford)H-Index: 68
view all 3 authors...
The Physiome Project of the International Union of Physiological Sciences (IUPS) is attempting to provide a comprehensive framework for modelling the human body using computational methods which can incorporate the biochemistry, biophysics and anatomy of cells, tissues and organs. A major goal of the project is to use computational modelling to analyse integrative biological function in terms of underlying structure and molecular mechanisms. To support that goal the project is establishing web-a...
153 CitationsSource
#1Yuri Lazebnik (CSHL: Cold Spring Harbor Laboratory)H-Index: 35
This article by Yu. Lazebnik, “Can a Biologist Fix a Radio? — or, What I Learned while Studying Apoptosis” has already been published in English (Cancer Cell, 2002, 2, 179–182) and in Russian (Uspekhi Gerontologii, 2003, No. 12, 166–171). Nevertheless, we have undertaken its secondary publication in our journal for two reasons: first, our journal has different readers, and, second, the great significance of this manifest of Yuri Lazebnik. The author in bright and clever form shows the emerging n...
308 CitationsSource
#1Alan Garny (University of Oxford)H-Index: 26
#2Penelope J. Noble (University of Oxford)H-Index: 13
Last. Denis Noble (University of Oxford)H-Index: 68
view all 4 authors...
Abstract This paper compares recent mathematical models of rabbit sino-atrial node pacemaker cell activity [Cellular and Neuronal Oscillators, Dekker, New York, 1989, p. 59; Am. J. Physiol. 266 (1994) C832; J. Theor. Biol. 181 (1996) 245; Am. J. Physiol. 279 (2000) H397] and evaluates them with the perspective of developing detailed multicellular models of the right atrium. (i) All evaluated models reproduce control action potential shapes, which have been recorded experimentally (although one o...
10 CitationsSource
In this issue of the PNAS, Papadatos et al. (1) analyze the mechanism of arrhythmia in the heart after targeted disruption of the cardiac sodium channel, Scn5a. They combine a wide variety of techniques (including genetic deletion, cellular electrophysiology, morphology, and electrocardiography) in an integrated approach to unravel the sequence of events all of the way from the genetic to the whole organism level. They are therefore able to show that the effect of the deletion is to reduce the i...
49 CitationsSource
#1Denis Noble (University of Oxford)H-Index: 68
Successful physiological analysis requires an understanding of the functional interactions between the key components of cells, organs, and systems, as well as how these interactions change in disease states. This information resides neither in the genome nor even in the individual proteins that genes code for. It lies at the level of protein interactions within the context of subcellular, cellular, tissue, organ, and system structures. There is therefore no alternative to copying nature and com...
509 CitationsSource
#1Jonathan LyttonH-Index: 1
2 Citations
The year 2001 saw a remarkable burst of interest in biological simulation, with several international meetings on the subject, and the inclusion, by journals, of web site references from which published models can be downloaded. So, why has all this happened so suddenly?
147 CitationsSource
Cited By12
Newest
#1Anthony CartwrightH-Index: 1
#2Brian MatthewsH-Index: 1
Source
#1Sivaraman Dandapani (Broad Institute)H-Index: 12
#2Lisa A. Marcaurelle (Broad Institute)H-Index: 10
Compounds accessed through diversity-oriented synthesis (DOS) are showing promise in modulating the activities of several targets that are currently considered ‘undruggable’. Recently many new DOS pathways have been developed employing multi-component reactions, cycloadditions, ring-closing metathesis and tandem processes. Functional group pairing and ‘build/couple/pair’ strategies have been described as a means for generating structural diversity. Efforts have also been directed towards develop...
125 CitationsSource
#1Arsia Amir Aslani (Grenoble School of Management)H-Index: 3
#2Vincent Mangematin (Grenoble School of Management)H-Index: 28
The drug discovery sector is being revolutionized by the current rate of advances in the public and private human genome projects and by the development of new technologies for biomarker testing. In effect, as the genetic roots of disease, disease progression and treatment effectiveness are uncovered, the demand for sophisticated prognostic, diagnostic and monitoring tests will be increasing. Already this has led to the development of innovative diagnostics products meeting the criteria of impro...
55 CitationsSource
#1Jean-Pierre BoisselH-Index: 27
#2Michel CucheratH-Index: 3
Last. François-Henri BoisselH-Index: 3
view all 5 authors...
3 CitationsSource
#1Antoine Soubret (Novartis)H-Index: 3
#2Gabriel Helmlinger (Novartis)H-Index: 14
Last. Anna Georgieva (Novartis)H-Index: 6
view all 5 authors...
Summary: Despite an impressive battery of preclinical cardiac electrophysiology experimental models and the assessment of QT during clinical trials, the risk of Torsades de Pointes (TdP), a potentially lethal ventricular arrhythmia, remains among the common reasons for drug market withdrawal or lack of approval. Due to the low prevalence of TdP, development of statistical evidence that other clinical markers could be better predictors of TdP has proven challenging. Preclinical studies have provi...
9 CitationsSource
Abstract Drug discovery companies are coming under increasing pressure to prove the long-term safety of their products more precisely, and to provide more data on them. As highlighted by Vioxx, for many drugs, the existence of adverse drug reactions (ADRs) becomes apparent once the compound has been extensively prescribed and a population base of considerable size has been exposed to the therapeutic agent. The ability to make decisions regarding termination of clinical development of a non-viabl...
11 CitationsSource
#1Wouter Boon (UU: Utrecht University)H-Index: 15
#2Ellen H.M. Moors (UU: Utrecht University)H-Index: 20
Due to uncertainties of several aspects of emerging health technologies, there is a need to anticipate these developments early. A first step would be to gather information and develop future visions about the technology. This paper introduces metaphor analysis as a novel way to do this. Specifically, we study the future of pharmacogenomics by comparing this technology with orphan drugs, which are more established and often act as a model with comparable (economic, research organisation, etc.) c...
33 CitationsSource
#1Marc K. Hellerstein (University of California, Berkeley)H-Index: 63
Contemporary drug discovery and development (DDD) is dominated by a molecular target-based paradigm. Molecular targets that are potentially important in disease are physically characterized; chemical entities that interact with these targets are identified by ex vivo high-throughput screening assays, and optimized lead compounds enter testing as drugs. Contrary to highly publicized claims, the ascendance of this approach has in fact resulted in the lowest rate of new drug approvals in a generati...
46 CitationsSource
The generation of cardiac pacemaker activity is a complex phenomenon which requires the coordinated activity of different membrane ionic channels, as well as intracellular signalling factors including Ca2+ and second messengers. The precise mechanism initiating automaticity in primary pacemaker cells is still matter of debate and certain aspects of how channels cooperate in the regulation of pacemaking by the autonomic nervous system have not been entirely elucidated. Research in the physiopatho...
13 CitationsSource
#1Stephan PhilippiH-Index: 7
#2Jacob Köhler (Rothamsted Research)H-Index: 10
A prerequisite to systems biology is the integration of heterogeneous experimental data, which are stored in numerous life-science databases. However, a wide range of obstacles that relate to access, handling and integration impede the efficient use of the contents of these databases. Addressing these issues will not only be essential for progress in systems biology, it will also be crucial for sustaining the more traditional uses of life-science databases.
72 CitationsSource